In this study, we applied bioinformatics to search for genes that are both related to SLE clinical evaluation scales (SLEDAI) and serological indicators (anti-dsDNA, C3, and C4) and discovered DDX60 as the candidate biomarker. This evidence concerns the gene C3 and systemic lupus erythematosus.